[1] Brenner DA.Reversibility of liver fibrosis[J].Gastroenterol Hepatol, 2013, 9(11):737-739. [2] Aydin MM, Akcali KC.Liver fibrosis[J]. Turk J Gastroenterol, 2018, 29(1):14-21. [3] Seki E, Brenner DA.Recent advancement of molecular mechanisms of liver fibrosis[J]. J Hepatobiliary Pancreat Sci, 2015, 22(7):512-518. [4] Campana L, Iredale JP.Regression of Liver Fibrosis[J].Semin Liver Dis, 2017, 37(1):1-10. [5] Regev A, Berho M, Jeffers LJ, et al.Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection[J]. Am J Gastroenterol, 2002, 97(10):2614-2618. [6] Maharaj B, Maharaj RJ, Leary WP, et al.Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver[J]. Lancet, 1986, 1(8480): 523-525. [7] 段维佳, 王晓明, 王宇, 等. FibroTouch和FibroScan检测评估慢性乙型肝炎患者肝纤维化程度的诊断价值[J]. 中华实验和临床病毒学杂志, 2018,32(4):399-402. [8] 秦敏. 慢性乙型肝炎肝硬化FibroScan测量结果与肝穿刺病理的关系[J]. 肝脏杂志, 2019, 24(6):674-676. [9] Xu XY, Wang WS, Zhang QM, et al.Performance of common imaging techniques vs serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis[J]. World J Clin Cases, 2019, 7(15):2022-2037. [10] 张显怡, 纪若云, 蔡小丽, 等. 3.0T磁共振弹性成像评价非酒精性脂肪肝及预测脂性肝炎[J].中国临床医学影像杂志, 2019, 30(12):859-862. [11] Xiao H, Shi M, Xie Y, et al.Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: A systematic review and meta-analysis[J]. PloS one, 2017, 12(11):e0186660. [12] 沈萍, 马盛元, 许华宇, 等. MR弹性成像对慢性乙型肝炎肝纤维化的诊断价值[J]. 中华放射学杂志, 2019, 53(8):633-634. [13] 王威, 温锋, 赵相轩, 等. 磁共振弹性成像评价肝纤维化分期的Meta分析[J]. 中国临床医学影像杂志, 2015,26(05):329-333+354. [14] 张豪, 邹立秋, 张凯, 等. MR多参数成像诊断肝纤维化分期的价值[J]. 中华放射学杂志, 2019, 53(10):900-904. [15] Obmann VC, Mertineit N, Berzigotti A, et al.CT predicts liver fibrosis: Prospective evaluation of morphology- and attenuation-based quantitative scores in routine portal venous abdominal scans[J]. PloS one, 2018, 13(7): e0199611. [16] Yasaka K, Akai H, Kunimatsu A, et al.Deep learning for staging liver fibrosis on CT: a pilot study[J]. Eur Radiol, 2018,28(11):4578-4585. [17] Li J, Wang J, Lei L, et al.The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies[J]. Eur Radiol, 2019, 29(12):6519-6528. [18] An C, Lee CH, Byun JH, et al.Intraindividual Comparison between Gadoxetate-Enhanced Magnetic Resonance Imaging and Dynamic Computed Tomography for Characterizing Focal Hepatic Lesions: A Multicenter, Multireader Study[J].Korean J Radiol, 2019,20(12):1616-1626. [19] Vreugdenburg TD, Ma N, Duncan JK, et al.Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis[J]. Int J Colorectal Dis, 2016, 31(11): 1739-1749. [20] Ippolito D, Famularo S, Giani A, et al.Estimating liver function in a large cirrhotic cohort: Signal intensity of gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI[J]. Dig Liver Dis, 2019, 51(10): 1438-1445. [21] Zhou ZP, Long LL, Qiu WJ, et al.Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic[J]. Abdom Radiol (NY), 2017, 42(9):2272-2278. [22] Yoon JH, Lee JM, Kang HJ, et al.Quantitative assessment of liver function by using gadoxetic acid-enhanced MRI: hepatocyte uptake ratio[J]. Radiology, 2019, 290(1): 125-133. [23] Nakagawa M, Namimoto T, Shimizu K, et al.Measuring hepatic functional reserve using T1 mapping of Gd-EOB-DTPA enhanced 3T MR imaging: A preliminary study comparing with (99m)Tc GSA scintigraphy and signal intensity based parameters[J]. Eur J Radiol, 2017, 92:116-123. [24] 饶圣祥, 胡道予, 宦怡, 等. 肝胆特异性MRI对比剂钆塞酸二钠临床应用专家共识[J]. 临床肝胆病杂志, 2016, 32(12):2236-2241. [25] Verloh N, Utpatel K, Haimerl M, et al.Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation[J]. Sci Rep, 2015, 5:15408. [26] Hako R, Kristian P, Jarcuska P, et al.Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging[J].Can J Gastroenterol Hepatol, 2019, 2019: 3024630. [27] Katsube T, Okada M, Kumano S, et al.Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging[J]. Invest Radiol, 2011, 46(4): 277-283. [28] Haimerl M, Verloh N, Zeman F, et al.Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry[J].Sci Rep, 2017, 7:43347. [29] Haimerl M, Fuhrmann I, Poelsterl S, et al.Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time (13)C-methacetin breath test[J].Eur Radioly, 2018,28(9):3591-3600. [30] Sheng RF, Wang HQ, Yang L, et al.Assessment of liver fibrosis using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance[J]. Dig Liver Dis, 2017, 49(7): 789-795. [31] Pan S, Wang XQ, Guo QY.Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging[J].World J Gastroenterol, 2018, 24(18): 2024-2035. [32] 蒋辉, 曲金荣, 邵楠楠, 等. Look-Locker和B1修正变量翻转角技术在正常乳腺组织T-1值测量中的对照研究[J]. 放射学实践, 2019, 34(1):26-29. |